Global 14-Alpha Demethylase Inhibitors Pipeline Insight Report 2022 - ResearchAndMarkets.com

The "14-alpha demethylase inhibitors - Pipeline Insight, 2022" clinical trials has been added to ResearchAndMarkets.com's offering.



This "14-Alpha Demethylase Inhibitors - Pipeline Insight, 2022" report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in 14-Alpha Demethylase Inhibitors pipeline landscape.

It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space

Key Questions

Current Scenario and Emerging Therapies:

  • How many companies are developing 14-Alpha Demethylase Inhibitors drugs?
  • How many 14-Alpha Demethylase Inhibitors drugs are developed by each company?
  • How many emerging drugs are in mid-stage, and late-stage of development for 14-Alpha Demethylase Inhibitors?
  • What are the key collaborations (Industry-Industry, Industry-Academia), Mergers and acquisitions, licensing activities related to the 14-Alpha Demethylase Inhibitors therapeutics?
  • What are the recent trends, drug types and novel technologies developed to overcome the limitation of existing therapies?
  • What are the clinical studies going on for 14-Alpha Demethylase Inhibitors and their status?
  • What are the key designations that have been granted to the emerging drugs?

Key Players

  • Mycovia Pharmaceuticals
  • Basilea Pharmaceutica
  • Hill Dermaceuticals
  • Zambon
  • Pulmocide
  • Angelini Pharmaceuticals
  • Biolab Sanus Farmaceutica
  • Astellas Pharma
  • Basilea Pharmaceutica
  • Pulmatrix
  • Seren Pharmaceuticals
  • Merck & Co
  • Laboratoires SMB
  • ProFem

Key Products

  • Oteseconazole
  • Isavuconazonium
  • Miconazole
  • ZP 059
  • PC-945
  • Benzydamine/econazole
  • BL-123
  • BAL 4815
  • PUR 1900
  • Fosravuconazole
  • Posaconazole
  • ITZ DPI
  • Prof-001

For more information about this clinical trials report visit https://www.researchandmarkets.com/r/egx5vu

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!